Events & Training for March 2013

Fragments 2013 - Fourth RSC-BMCS Fragment-based Drug Discovery meeting

04 March 2013 - 05 March 2013

The aim of the 4th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

STFC Rutherford Appleton Laboratory, Oxford, Didcot, UK

The 5th Annual World Congress of Vaccine

18 March 2013 - 20 March 2013

The annual congress WCV initiated by BIT Congress In 2008 has been accepted as an influential conference for worldwide vaccine professionals to discuss and develop the latest research breakthroughs as well as potential business opportunities. During 4 years’ successful running of WCV, the event has attracted more than 1600 participants from 56 countries who have revealed their broad experiences and deep expertise.

Hangzhou Blossom Water Museum Hotel, China

BioWales 2013

19 March 2013 - 20 March 2013

BioWales is one of the UK’s largest life sciences conferences and brokerage events held outside of London. Celebrating its eleventh year the 2013 conference will focus on the links between NHS, Industry and Academia in delivering tomorrow’s health solutions. The breadth of speakers at this year’s event will cater for the Life Sciences sector as a whole and will include representation from SMEs, entrepreneurs, multi-nationals, covering topics such as, medical devices sector, big pharma, industry advisors, academia, funding organisations, Government and clinicians.

Wales Millennium Centre, Cardiff, UK

ELRIG Research and Innovation

19 March 2013

Cellular Toxicology in Drug Discovery Innovation in Cell Culture Tags & Binders The objective is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry. The 3 sessions will attract world class speakers discussing challenges and opportunities in developing new technologies. The scientific sessions have been chosen as they represent major areas of research important to all areas of drug discovery. The scientific sessions will be complemented by a poster session, a vendor exhibition with over 35 exhibitors, including an Innovation Zone where fledgling companies will showcase their new technologies.

Telford International Centre, UK

Biomarker Summit 2013

20 March 2013 - 22 March 2013

The summit will discuss a wide range of issues such as biomarker identification and validation strategies, patient stratification, enabling omics technologies, bioinformatics and systems biology techniques, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Hilton San Francisco Financial District, San Francisco, CA, USA

6th Oncology Biomarkers

20 March 2013 - 22 March 2013

This conference will discuss a wide range of issues in the oncology biomarker field such as novel approaches to biomarker discovery, diagnostic and therapeutic development for cancer, utilization of next-generation sequencing in the clinic, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Hilton San Francisco Financial District, San Francisco, CA, USA

2nd Inflammatory & Immunological Biomarkers

20 March 2013 - 22 March 2013

This conference will discuss a wide range of issues in the biomarker field specific to inflammatory and immunological therapeutic areas. Topics such as novel approaches to biomarker discovery, enabling technologies, regulatory and reimbursement trends and the development of companion diagnostics will be discussed. Specific disease areas include cardiovascular disease, metabolic diseases, arthritis, autoimmune diseases, kidney / renal disease and inflammatory bowel disease. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Hilton San Francisco Financial District, San Francisco, CA, USA

2nd Neurological Biomarkers

20 March 2013 - 22 March 2013

This conference will discuss a wide range of issues in the biomarker field related to neuroscience. Topics of this conference include updates on biomarkers in Alzheimer’s disease, CSF and blood-based biomarkers and imaging biomarkers. Biomarker data will also be presented in other specific neurological disorders such as Parkinson’s, MS, ALS, schizophrenia and pain. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Hilton San Francisco Financial District, San Francisco, CA, USA

5th Ocular Diseases & Drug Development

21 March 2013 - 22 March 2013

Hilton San Francisco Financial District, San Francisco, CA, USA

Discovery Summit 2013

21 March 2013 - 22 March 2013

The 13th annual Global Discovery Summit taking place from the 21st – 22nd March 2013, at the LE MERIDIEN, Monte Carlo, Monaco, offers global R&D professionals and drug discovery service providers an intimate environment for a focused discussion of key new drivers shaping discovery research and development. Leading-edge sponsors will have the opportunity to offer valuable solutions and expertise by meeting and interacting with these senior pharma and biotechnology leaders through various networking opportunities and business one-to-one meetings. In addition, sponsors will have the chance to form useful business relationships through attending strategic summit sessions. To secure your seat or for more information, email us at summits-emea@marcusevans.com

Le Meridien, Monte Carlo, Monaco, France

6th Annual Proteins Congress 2013

25 March 2013 - 26 March 2013

Oxford Global Conferences are proud to present the 6th Annual Proteins Congress 2013, which is to be held on the 25th & 26th March in London, UK. Centered around the key topic areas of Protein Science, Protein Technologies, Expression, Characterisation, Engineering and Production, the event is the single most focused proteins event in Europe. The congress highlights opportunities in the protein and antibody market by focusing on current trends, technologies and business models. The event will also address relevant challenges and bottlenecks, for example, the new Immunogenicity stream offers practical strategies for dealing with one of the industry’s biggest challenges.

Novotel London West, London, UK

3rd Annual Vaccines Congress 2013

25 March 2013 - 26 March 2013

Oxford Global Conferences are proud to present the 3rd Annual Vaccines Congress, taking place on the 25th & 26th March 2013 in London. The conference programme consists of over 35 world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussions. Over the two days, key opinion leaders will explore pioneering solutions and critical opportunities in preclinical development, clinical design and process enhancement.

Novotel London West, London, UK